Sunitinib versus sorafenib as initial targeted therapy for...

  • Main
  • 2020 / 3
  • Sunitinib versus sorafenib as initial targeted therapy for...

Sunitinib versus sorafenib as initial targeted therapy for mCC-RCC with favourable/intermediate risk: multicentre randomised trial CROSS-J-RCC

Tomita, Yoshihiko, Naito, Sei, Sassa, Naoto, Takahashi, Atsushi, Kondo, Tsunenori, Koie, Takuya, Obara, Wataru, Kobayashi, Yasuyuki, Teishima, Jun, Takahashi, Masayuki, Matsuyama, Hideyasu, Ueda, Take
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Clinical Genitourinary Cancer
DOI:
10.1016/j.clgc.2020.01.001
Date:
March, 2020
File:
PDF, 902 KB
2020
Conversion to is in progress
Conversion to is failed